1 Min Read
Oct 5 (Reuters) - Velicept Therapeutics:
* Announces FDA Acceptance Of IND Application Of novel, once- daily formulation of Solabegron for the treatment of overactive bladder Source text for Eikon:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.